714 related articles for article (PubMed ID: 8675088)
1. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
2. Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.
Furrie E; Macfarlane S; Cummings JH; Macfarlane GT
Gut; 2004 Jan; 53(1):91-8. PubMed ID: 14684582
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis.
Khoo UY; Bjarnason I; Donaghy A; Williams R; Macpherson A
Gut; 1995 Jul; 37(1):63-70. PubMed ID: 7672683
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A.
Oriishi T; Sata M; Toyonaga A; Sasaki E; Tanikawa K
Gut; 1995 Jun; 36(6):891-6. PubMed ID: 7615279
[TBL] [Abstract][Full Text] [Related]
5. Mucosal IgG in inflammatory bowel disease - a question of (sub)class?
Castro-Dopico T; Clatworthy MR
Gut Microbes; 2020 Nov; 12(1):1-9. PubMed ID: 31480888
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease.
Lin R; Chen H; Shu W; Sun M; Fang L; Shi Y; Pang Z; Wu W; Liu Z
J Transl Med; 2018 Dec; 16(1):359. PubMed ID: 30558634
[TBL] [Abstract][Full Text] [Related]
7. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis.
Biancone L; Mandal A; Yang H; Dasgupta T; Paoluzi AO; Marcheggiano A; Paoluzi P; Pallone F; Das KM
Gastroenterology; 1995 Jul; 109(1):3-12. PubMed ID: 7797027
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin coating of faecal bacteria in inflammatory bowel disease.
van der Waaij LA; Kroese FG; Visser A; Nelis GF; Westerveld BD; Jansen PL; Hunter JO
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):669-74. PubMed ID: 15201580
[TBL] [Abstract][Full Text] [Related]
9. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Wu KC; Mahida YR; Priddle JD; Jewell DP
Clin Exp Immunol; 1989 Oct; 78(1):37-41. PubMed ID: 2805422
[TBL] [Abstract][Full Text] [Related]
11. Mucosal flora in Crohn's disease and ulcerative colitis - an overview.
Swidsinski A; Loening-Baucke V; Herber A
J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():61-71. PubMed ID: 20224153
[TBL] [Abstract][Full Text] [Related]
12. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.
Kleessen B; Kroesen AJ; Buhr HJ; Blaut M
Scand J Gastroenterol; 2002 Sep; 37(9):1034-41. PubMed ID: 12374228
[TBL] [Abstract][Full Text] [Related]
13. Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.
Elliott TR; Hudspith BN; Wu G; Cooley M; Parkes G; Quiñones B; Randall L; Mandrell RE; Fagerquist CK; Brostoff J; Rayment NB; Boussioutas A; Petrovska L; Sanderson JD
Inflamm Bowel Dis; 2013 Oct; 19(11):2326-38. PubMed ID: 23989750
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease.
Gordon JN; Pickard KM; Di Sabatino A; Prothero JD; Pender SL; Goggin PM; MacDonald TT
Inflamm Bowel Dis; 2008 Feb; 14(2):195-203. PubMed ID: 18022869
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.
Negroni A; Costanzo M; Vitali R; Superti F; Bertuccini L; Tinari A; Minelli F; Di Nardo G; Nuti F; Pierdomenico M; Cucchiara S; Stronati L
Inflamm Bowel Dis; 2012 May; 18(5):913-24. PubMed ID: 21994005
[TBL] [Abstract][Full Text] [Related]
17. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
Zhang P; Liu X; Guo A; Xiong J; Fu Y; Zou K
Dig Dis Sci; 2016 Sep; 61(9):2608-18. PubMed ID: 27056038
[TBL] [Abstract][Full Text] [Related]
18. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
[TBL] [Abstract][Full Text] [Related]
19. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
20. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
